Individualized exercise in chronic non-specific low back pain: a systematic review with meta-analysis on the effects of exercise alone or in combination with psychological interventions on pain and disability ================================================================================================================================================================================================================ * Johannes Fleckenstein * Philipp Flössel * Tilman Engel * Laura Klewinghaus * Josefine Stoll * Martin Behrens * Daniel Niederer ## ABSTRACT This systematic review with meta-analysis and meta-regression investigated the effects of individualized exercise interventions consisting with or without combined psychological intervention on pain intensity and disability in patients with chronic non-specific low-back-pain. Databases were searched up to 31 January 2022 and we selected randomized controlled trials involving adults with chronic non-specific low-back-pain being treated with individualized/personalized/stratified exercise interventions with or without psychological treatment compared to any control. Fifty-eight studies (n = 10084) were included. At short-term follow-up (12 weeks), low-certainty evidence for pain intensity (SMD -0.28 [95%CI -0.42 to -0.14]) and very low-certainty evidence for disability (−0.17 [-0.31 to -0.02]) indicates effects of individualized versus active exercises, and very low-certainty evidence for pain intensity (−0.40; [-0.58 to -0.22])), but not (low-certainty evidence) for disability (−0.18; [-0.22 to 0.01]) compared to passive controls. At long-term follow-up (1 year), moderate-certainty evidence for pain intensity (−0.14 [-0.22 to -0.07]) and disability (−0.20 [-0.30 to -0.10]) indicates effects versus passive controls. Sensitivity analyses indicates that the effects on pain, but not on disability (always short-term and versus active treatments) were robust. Pain reduction caused by individualized exercise treatments in combination with psychological interventions (in particular behavioural-cognitive therapies) (−0.28 [-0.42 to -0.14], low certainty) is of clinical importance. Certainty of evidence was downgraded mainly due to evidence of risk of bias, publication bias and inconsistency that could not be explained. Individualized exercise can be recommended from a clinical point of view to treat pain and disability in chronic non-specific low-back-pain. Sub-group analysis suggests a combination of individualized exercise (especially motor-control based treatments) with behavioural therapy interventions to booster effects. Certainty of evidence was moderate for long-term follow-up. **PROSPERO registration** CRD42021247331 Keywords * sports medicine * pain therapy * spine * multimodal * integrative medicine ## Introduction Back pain, in particular chronic non-specific low back pain, is one of the most serious public-health problems worldwide.21 Its global median 1-year period prevalence in the adult population is around 37%.21 Together with the consequences of low back pain, such as loss of labour productivity or rates of hospital admissions, this high number of involved people results in tremendous direct and indirect costs for societies’ healthcare systems and economies.64 For those affected, pain symptoms are often accompanied by functional limitations and decreased performance, substantially deteriorating the quality of their individual and family lives.57, 63 Exercise therapy and psychological (especially cognitive behavioural) therapy, both as stand-alone treatments but especially in combination, are considered being effective in the treatment of chronic low back pain.45 Still, current research reveals only relatively small and heterogeneous effects when combining exercise and cognitive-behavioural therapies.19, 22, 25 This is likely to be attributed to inter-individual heterogeneities in the effects.33 Stratified or even individualized/personalized therapies may be the potential key to increase the (group and individual) therapeutic effect.23 On a somatic-biological level, patients with low back pain predominantly present deficits in motor control strategies, though varying in its characteristics between individuals.40, 59 On a psychosocial level, dysfunctional cognition (fear-avoidance-beliefs, catastrophizing) and dysfunctional pain behaviour (kinesiophobia) are known risk factors for chronification or for a worsening of symptoms in chronic low back pain.39, 55 Functional strength/restoration, coordination (Pilates, McKenzie) and stabilization training are, based on meta-analytic evidence on comparative effectiveness, likely to be the most effective types of exercise in the management of chronic non-specific low back pain.23, 42 Simply and mechanistically expressed, all these training modalities improve motor control.59 Unfortunately, such effects are only of limited validity for the affected individuals due to the presence of heterogeneous influencing psychosocial factors in group analyses.42 The latter has been addressed by a variety of validated individualized psychological interventions against chronic low back pain. A prominent approach is the STarT Back Screening Tool, used to classify patients with low back pain into tailored focus therapy groups (exercises and cognitive-behavioural strategies) based on bio-psycho-social factors.27 Stratification, or even better personalisation/individualisation of exercise and psychological interventions may consequently lead to better therapeutic outcomes (fewer days of illness, improvement of symptomatology) than mono-interventions or, even non-personalized therapies only.1532 Consequently, individualized exercise with or without psychological interventions were investigated by a large number of clinical trials. However, individualisation as an independent variable defining exercise has not been assessed on a meta-analytical level before. There is one recently published review analysing the effects of classification-based exercise to treat chronic low back pain,56 showing small and no meaningful effects. However, this study focussed on classification systems and not on exercise that was individualized based on the patient’s needs. In addition, exercise was often combined with psychological interventions, which may have impacted the overall outcomes. Consequently, the aim of this systematic review with meta-analysis and –regression is to qualify and quantify the effects of individualized exercises as mono-therapies, or in combination with cognitive or behavioural types of psychological interventions. Adding many sensitivity analysis allows to distinguish active and passive controls, and to differentiate the type of individualized exercise. This consolidates previous knowledge and builds a bridge to known effects such as the above mentioned classification systems 56 or classical exercise.22 ## Methods The systematic review with meta-analysis and meta-regression protocol was developed using guidance from the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) statement,36 registered in the PROSPERO database (CRD42021247331, Date of registration in PROSPERO: 10 May 2021, Date of first submission: 09 April 2021, update 10 February 2022, available at: [https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=247331](https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=247331)). Studies were identified by searching multiple databases, including PubMed, Cochrane Central Register of Controlled Trials, EMBASE, Clarivate Web of Science, and Google Scholar from their inception to March 2021. The search terms were identified after preliminary searches of the literature and by comparing them against previous systematic reviews. A sensitive search strategy was used based on the recommendations of the Cochrane Back and Neck Group for ‘randomized controlled trials’ (RCT) and ‘low back pain’,14 combined with search terms for ‘exercise’. The full search strategy is presented in the supplementary data appendix B. In addition, reference lists of relevant reviews and included RCTs were manually searched, and citation tracking of all included trials was performed. A grey literature search in google scholar was further performed. The searches and inclusion criteria were restricted to English, German, French, Spanish, and Italian. We tested the eligibility criteria by piloting a small sample (10 trials). Two independent researchers (JF, PF) screened titles and abstracts of the publications retrieved by the search strategy and assessed the full texts for potential inclusion. Studies not meeting the inclusion criteria were discarded. Disagreements between researchers were resolved by discussion and consultation with a third reviewer (DN), if necessary. For the sake of brevity, the term (chronic) low back pain in this manuscript refers to chronic non-specific low back pain if not stated otherwise. ### Eligibility criteria This study followed the participants, interventions, comparisons, outcomes, and study design (PICOS) framework. ### Population The population of interest was patients suffering from chronic non-specific low back pain that have been treated with any approach of stratified, personalized and/or individualized exercise. Chronic non-specific low back pain is defined as pain without a known pathoanatomical cause 34, chronicity of pain lasting longer than 3 month, or recurrent low back pain defined as two episodes per year.22 All studies had to research populations were the aforementioned criteria were fulfilled for the majority of their included patients to be considered potentially eligible. ### Intervention (exposure) The interventions/exposures were all forms of individualized, tailored, personalized, or stratified exercise of any frequency, intensity, volume or type, with a duration of at least 4 weeks. Interventions that consisted of exercise alone or exercise combined with psychological interventions (i.e. behavioural or cognitive, or combined behavioural-cognitive therapy) were considered. ### Comparison Eligible comparators were all matched or non-matched conservative (non-surgery) control/comparator groups, that could be either active, passive, or no treatment (real) controls ### Outcomes We reported the following outcomes up to 1 year after randomisation: Pain intensity, measured with a pain scale (for example, visual analogue scale (VAS), numerical rating scale (NRS), or McGill pain score) Disability, measured with a back pain-specific scale (for example, the Roland-Morris Disability Questionnaire (RMDQ)49, or the Oswestry Disability Index (ODI)12). The two scales can be matched.5 All scores were normalized to VAS-scores (range 0 to 10, with 0 indicating no burden and 10 = maximum suffering from symptom).54 Planned secondary outcomes were the number of days of absence from work and a measure of quality of life. Study design: Only RCTs were eligible. Data extraction: We designed and piloted a data collection form created with Excel (Microsoft). Two researchers (JF, PF) independently extracted the study characteristics and outcome data. Disagreements were resolved through discussion or with assistance from a third researcher (DN), if necessary. From each study we extracted: number of study arms, predetermined duration of chronic non-specific low back pain, real duration of low back pain, number of participants (total and in study arms), age, sex, type of interventions (individualized, exercise, psychological), type of control, length of training period (both intervention and controls, training frequency (sessions per week), single training duration (minutes), number of adverse events. For the effect size calculations, change scores of the outcomes and standard deviations of the change scores of the outcomes were retrieved. If not directly retrievable from the studies, the required data was calculated/imputed from the available data (baseline, change score, follow-up-values, and their standard deviations) according to the formulas defined in the Cochrane handbook. In addition (or, were not applicable), missing data was requested from the corresponding authors. Effect sizes were processed as negative values (indicating a decrease in pain, which equals a symptom improvement), i.e. higher negative values indicate larger effect sizes. Study risk of bias assessment: Two researchers independently assessed the risk of bias (RoB) for the outcomes of interest of the included trials. We assessed the RoB for each study/outcomes using the following RoB assessment tools recommended by the Cochrane Collaboration:26 random sequence generation, allocation concealment, blinding of participants, providers and outcome assessment, incomplete outcome data (dropouts) and selective outcome reporting. In the selective outcome data, we accounted for a broader assessment considering also the selective non-reporting RoB due to missing results in index meta-analyses (e.g., missing or unavailable outcome results crosschecked from method plans) according to published criteria.43, 44 For each study, the score of the items indicated high, low or some concerns (not enough information reported) regarding RoB.26 As both pain and disability are considered comparable in terms of the impact of bias on the effect sizes, they were rated cumulatively. ### Certainty assessment Certainty of evidence was assessed applying the framework as provided by the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system of rating quality of evidence and grading strength of recommendations in systematic reviews (see supplementary data appendix F.17 The five GRADE domains were applied: study limitations, indirectness, inconsistency, imprecision and publication bias. To interpret the clinical relevance of the meta-analyses results, we considered a 1.5-point difference in pain and a 1.0-point difference on a 10 point VAS in disability to be clinically important for the comparisons of exercise versus any comparator group .22 We interpreted smaller differences in the effectiveness of exercise treatments compared to other conservative treatments as ’probably meaningful’, when the 95% confidence interval was entirely on one side of the no effect line. This is relevant given similar inconveniences and adverse effects for comparison of treatments considered in this review.47 ### Statistics:Meta-analysis and -regression For data pooling, random-effects meta-analyses were modelled. Main analyses were calculated separated by outcome (pain versus disability), by the combined comparator (active/exercise or passive comparator group), and by the intervention duration (short-and long-term-effects). Weighted standardized mean differences between the intervention and control/comparator groups (Hedge’s g) were used as effect size estimators. For pooling analyses, mean effect sizes and their 95% confidence intervals were calculated; summary estimate data were displayed using Forest plots. To test for overall effects, Z-statistics at a 5% alpha-error-probability level were calculated. Between-effects heterogeneity was assessed using the I2- and, using restricted maximum-likelihood estimators, Tau2-statistic. In case of heterogeneity (tau2 > 0) a prediction interval for the true outcomes was also provided. Sensitivity analyses were performed including only effect sizes from studies without a serious overall RoB and using the exercise type, the type of psychological intervention, and the characteristics of the comparator group. To detect outliers on study level, Studentized residuals and Cook’s distances were used. Outliers were Bonferroni-corrected with two-sided alpha = 0.05. To check the included studies for a potential publication bias, Funnel plots and Egger’s regression test, to check a potential funnel plot asymmetry using the standard error of the observed outcomes as predictor, were used. All pooled effects analyses were performed using the MAJOR package for jamovi (version 1.6.23, jamovi.org, Sydney, Australia). Meta-regressions were further calculated. Independent variables were the intervention duration, the type of comparator (active versus passive), known effective versus rather ineffective exercise types, control group matched to the intervention group “yes versus no”, behavioural treatment “yes versus no”, number of the participants, overall RoB rating, and mean age of the participants. The dependent variables were the effect sizes for pain and disability (continuous). For the regression model, a syntax for IBM SPSS was used (D.B. Wilson; Meta-Analysis Modified Weighted Multiple Regression; MATRIX procedure Version 2005.05.23). Inverse variance-weighted regression models with random intercepts and fixed slopes were calculated. Homogeneity analysis (Q and p-values), meta-regression estimates (95% confidence intervals and p-values), and Z-statistics were calculated. ## Results Our electronic database searches identified 1,172 unique citations. We screened the full-texts of 109 publications, identified 73 as potentially eligible, and included 58 RCTs of individualized exercise treatment for chronic low back pain in this systematic review with meta-analysis and meta-regression. At least, 53 studies contained sufficient data to be included into the qualitative analysis, with five studies lacking sufficient follow-up data. Figure 1 provides detail about the flow of citations and studies through our search and selection process.References to included and excluded studies at the full-text stage are provided within supplementary data appendix D. ![Figure 1:](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2022/02/11/2021.12.16.21267900/F1.medium.gif) [Figure 1:](http://medrxiv.org/content/early/2022/02/11/2021.12.16.21267900/F1) Figure 1: Flow Chart. RCT = randomized controlled trial, LBP = chronic non-specific low back pain Study characteristics: A total of 10084 participants were included in 58 trials (Table 1, supplementary data appendix D). The sample size of trials ranged between 69 and 238 participants (IQR) with a median of 121 participants for each study. Reported inclusion criteria for low back pain in trials was more than 12 (6 to 12) weeks prior to study inclusion, and if reported the median time of perceived burden was 111 (55-450) weeks. Thirteen studies included as well sub-chronic pain duration and sub-acute intervals of low back pain,2, 4, 8, 13, 16, 20, 24, 29, 31, 46, 48, 52, 60 but consisted with a major share of participants with chronic or chronic-recurrent pain. View this table: [Table 1.](http://medrxiv.org/content/early/2022/02/11/2021.12.16.21267900/T1) Table 1. Characteristics of included studies. Inclusion criteria of LBP indicates if the study had a defined onset of the current LBP episode, whereas duration of LBP refers to the overall duration of the complaint if indicated. I = individualized group, C(s) = control group(s), SMT = sensorimotor training, BT = behavioural therapy, CBT = cognitive behavioural therapy, LBP = chronic non-specific low back pain, w = weeks, y = years, n = number, min = minute, RoB = Risk of Bias The median year of publication of RCTs was 2015 (range 1993–2021). The median age of participants was 45.4 years (IQR 41.7-49.4), and the median percentage of females was 55.7% (50.2%–62.5%). The median training period was 8.0 (6.0-12.0) weeks, and the median number of training sessions per week was 2.0 (1.5-3.0) for the individualized exercise and 1.5 (1.0-2.4) for the control exercises. Duration of training was 50.0 (35.0-60.0) minutes for individualized, and 50.0 (30.0-60.0) minutes for control exercise. Twenty-four (41.4%) studies investigated mixed individualized exercises, and 22 studies (37.9%) sensorimotor training (SMT). Other individualized interventions included aerobic (n = 5), pilates (n = 1), McKenzie (n = 4), back schools (n = 4), and yoga (n = 1). Thirty-four (58.6%) studies added some form of psychological intervention to the exercise procedure, i.e., cognitive-behavioural therapy (n = 9, 15.5%), behavioural therapy (n = 2, 3.4%), or other (n = 24, 34.8%). In total, 61 control groups could be identified, with eleven studies presenting more than one control group. Forty-two (68.9%) of control interventions were non-individualized active exercises, and 21 (34.4%) no treatments with advice to stay active and usual care. Other controls were true controls (no treatment, n = 3), passive controls (n = 5), and medications (n = 1). Eleven of these control groups were matched (i.e., same type of exercise except individualisation). There was not sufficient data to analyse secondary data. ### RoB assessement RoB assessments on study level (as derived from the outcomes) are summarized in Figure 2 and supplementary data appendix E. Of the 58 studies, 26 (44.3%) had an overall unclear RoB (i.e., some concerns), and 32 (55.7%) a high overall RoB. In summary, there was a considerably high overall RoB and this due to deviations from intended interventions (Figure 2, supplementary data appendix C). ![Figure 2.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2022/02/11/2021.12.16.21267900/F2.medium.gif) [Figure 2.](http://medrxiv.org/content/early/2022/02/11/2021.12.16.21267900/F2) Figure 2. Risk of bias rating on an individual study level, displayed as traffic light plot for each study/outcome with green lights = low, yellow = unclear/moderate, and red = high risk of bias. The aggregate Cochrane Risk-of-bias appraisal results summary plot is displayed in the supplementary data appendix E. The funnel plot (supplementary data appendix E) highlights the RoB across studies (publication bias on meta-level for the main outcomes pain and disability (short-term, in comparison to any comparator group). For the detailed main analyses, both the rank correlation and the regression test indicated no funnel plot asymmetry for pain in the short-term follow-up versus active treatments (Egger’s regression test = -1.407, p = 0.2; rank correlation: -0.202, p = .1) but versus passive treatments (test = -3.313, p = 0.001; rank = - 0.373, p = 0.009). In the long-term follow-ups on pain, no publication bias was indicated (rank = 0.117, Egger = 0.18, both p > .05; versus active; rank = 0.029, Egger = 0.288, both p > .05 versus passive). No funnel plot asymmetry was detected in any disability model (rank between -0.029 and -0.173, Eggers between -0.623 and -0.030, all p> .05). Only for the pain model of short-term follow-up versus passive measures, a publications bias is supposable, whereas it is unlikely for the pain contrast to active measures or long-term pain and disability models. ### Overall GRADE assessment The overall certainty of the evidence was rated as low for meta-analytic outcomes of self-reported pain and disability. The main reasons for downgrading the evidence were RoB, inconsistency, and publication bias. Imprecision and indirectness were no problem, as this systematic review encompassed specific populations, types of interventions, and outcome measures (see Table 2 and the certainty of evidence section in supplementary data appendix F,). View this table: [Table 2.](http://medrxiv.org/content/early/2022/02/11/2021.12.16.21267900/T2) Table 2. Sensitivity analysis of outcomes pain and disability at short-term follow-up comparing individualized exercise with active controls. Bold standardized mean differences (SMD) indicate significant effects towards the individualized group. Certainty of evidence was rated according to the GRADE system.18 SMT = sensorimotor training ### Results of individual studies Pain intensity was assessed in 46 studies at short-term (closest to 12 weeks after randomisation or after 12 weeks of intervention) or at long-term follow-up (closest to 12 months after randomisation). Mean pain intensity at baseline was 4.90 (standard deviation 1.38) on a VAS in the individualized groups and 4.89 (1.45) in controls. Pain following individualized exercise was reduced to 2.88 (1.25) at 12 weeks and 3.15 (1.09) at 52 weeks. Pain intensity in controls decreased to 3.62 (1.24) at 12 weeks and 3.49 (1.14) at 52 weeks. Disability was assessed in 45 studies at short-term or at long-term follow-up. Mean disability at baseline was 3.53 (1.42) VAS in the individualized groups and 3.46 (1.51) in controls. Disability following individualized exercise was reduced to 2.41 (1.48) at 12 weeks and 2.47 (1.39) at 52 weeks. At 12 and 52 weeks, disability in controls was reduced to 2.65 (1.51) and 2.70 (1.21),. For individual differences in studies see supplementary data appendix C. ### Pain intensity Individualized exercise significantly reduced pain compared with all active comparators at short-term follow-up (closest to 12 weeks after randomisation; I2 = 73%, k = 32 SMD −0.28; 95% CI −0.42 to – 0.14; Figure 3), but not at long-term follow-up (closest to 12 months; I2 = 41%, k = 16 SMD −0.10; 95% CI −0.21 to 0.01; supplementary data appendix H). Mean clinically important differences did not suggest relevance at short-term (−0.67 cm VAS) or long-term follow-up (−0.19). ![Figure 3.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2022/02/11/2021.12.16.21267900/F3.medium.gif) [Figure 3.](http://medrxiv.org/content/early/2022/02/11/2021.12.16.21267900/F3) Figure 3. Forest plot for the effect sizes for the short-term follow-up (closest to 12 weeks following randomisation) of individualized exercise versus other active treatments on pain intensity. The plot depicts model fit, individual study and pooled effect size estimates (standardized mean differences (SMD) and corresponding 95% confidence intervals (95% CI)). The size of the boxes corresponds to the respective studies’ (inverse variance) weighting. The intensity of pain following the intervention showed that individualized exercise significantly reduced pain compared with passive treatments or true control at short-term follow-up (I2 = 89%, k = 32 SMD −0.40; 95% CI −0.58 to –0.22; Figure 4), and at long-term follow-up (I2 = 29%, k = 17 SMD −0.14; 95% CI −0.22 to –0.07; supplementary data appendix H). Mean clinically important differences did not suggest relevance at short-term (−0.33 cm VAS) or long-term follow-up (−0.18). ![Figure 4.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2022/02/11/2021.12.16.21267900/F4.medium.gif) [Figure 4.](http://medrxiv.org/content/early/2022/02/11/2021.12.16.21267900/F4) Figure 4. Forest plot for the effect sizes for the short-term follow-up (closest to 12 weeks following randomisation) of individualized exercise versus passive treatments, true control, and usual care on pain intensity. The plot depicts model fit, individual study and pooled effect size estimates (standardized mean differences (SMD) and corresponding 95% confidence intervals (95% CI). The size of the boxes corresponds to the respective studies’ (inverse variance) weighting. ### Disability Under consistency, individualized exercise did significantly reduce disability compared with all active comparators at short-term follow-up (I2 = 73%, k = 32 SMD −0.17; 95% CI −0.31 to –0.02, Figure 5), but not at long-term follow-up (I2 = 69%, k = 15 SMD −0.12; 95% CI −0.27 to 0.03, supplementary data appendix H). Mean clinically important differences did not suggest relevance at short-term (−0.33 cm VAS) or long-term follow-up (−0.18). ![Figure 5.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2022/02/11/2021.12.16.21267900/F5.medium.gif) [Figure 5.](http://medrxiv.org/content/early/2022/02/11/2021.12.16.21267900/F5) Figure 5. Forest plot for the effect sizes for the short-term follow-up (closest to 12 weeks following randomisation) of individualized exercise versus other active treatments on disability. The plot depicts model fit, individual study and pooled effect size estimates (standardized mean differences (SMD) and corresponding 95% confidence intervals (95% CI). The size of the boxes corresponds to the respective studies’ (inverse variance) weighting. Individualized exercise did not reduced disability compared with passive treatments or true control at short-term follow-up I2 = 54%, k = 22 SMD −0.09; 95% CI −0.18 to 0.01, Figure 6) but significantly at long-term follow-up (I2 = 51%, k = 15 SMD −0.20; 95% CI −0.30 to –0.10, supplementary data appendix H). Mean clinically important differences did not suggest relevance at short-term (0.18 VAS) or long-term follow-up (−0.96). ![Figure 6.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2022/02/11/2021.12.16.21267900/F6.medium.gif) [Figure 6.](http://medrxiv.org/content/early/2022/02/11/2021.12.16.21267900/F6) Figure 6. Forest plot for the effect sizes for the short-term follow-up (closest to 12 weeks following randomisation) of individualized exercise versus passive treatments or true control on disability. The plot depicts model fit, individual study and pooled effect size estimates (standardized mean differences and corresponding 95% confidence intervals). The plot depicts model fit, individual study and pooled effect size estimates (standardized mean differences (SMD) and corresponding 95% confidence intervals (95% CI). The size of the boxes corresponds to the respective studies’ (inverse variance) weighting. ### Certainty of evidence Main outcomes on pain intensity have been graded with low (vs. active at short-and long-term) and very low at short-term and moderate at long-term (vs. passive interventions). Certainty of disability outcomes was graded as very low (vs. active) at short-and long-term) and moderate (vs. passive at short- and long-term, see *supplementary data appendix F*). #### Sensitivity and moderator analyses All effects at short-term follow-up were calculated in comparison to other active treatments (exercises). The effect on pain, but not on disability, was robust when only studies with utmost moderate overall RoB were pooled (according to Table 1, and *supplementary data appendix E)* Most further sensitivity analyses, i.e., i) individualized multimodal (mixed) exercise interventions, ii) individualized exercise in combination with psychological intervention, iii) individualized exercise interventions based on SMT, iv) only studies with matched control groups, v) only studies with the inclusion criterion of low back pain lasting for at least 12 weeks, and vi) only studies with an additional behavioural treatment showed individualized exercise to significantly reduce pain intensity at short-term follow-up compared with other active treatments, but not disability (Table 2, supplementary data appendix I1-I7). In contrast, the comparisons to vi) only true control comparators revealed superior effects by the individualisation in both pain and disability. Mean differences when compared to controls ranged from -0.09 to -1.27 VAS (depending on the sensitivity scenario) for pain intensity, with largest clinical effects for combined treatments of individualized exercise and cognitive behavioural therapy (−1.27 VAS), and from -0.09 to -0.80 for disability (see supplementary data appendix G). On an individual level, all effects of individualized exercise on pain were clinically important (> 1.50 VAS). Effects on disability were clinically important at both short-term and long-term follow-up, except for individualized exercise not including psychological interventions and studies including low back pain episodes shorter than 12 weeks. Controls showed clinical important effects when including psychological interventions, and on long-term disability. Dose-response relationships have been performed by means of meta-regression analysis (supplementary data appendix I8). The independent variables (intervention duration, type of comparator, distinction between rather effective or ineffective exercise, matched control group, additional psychological intervention, total study size (n), overall risk of bias rating, and mean age) explained 13% of the pain and 6% of the disability effect size heterogeneity. For pain, the only significant contributor was the training duration (in weeks, longer durations mediated larger effect sizes). For disability, no significant regressors could be identified (see supplementary data appendix I8). ### Adverse Events Adverse events have been reported by 14 (24%) of studies, with a total of 553 events, of which 50 (9%) were at least possibly treatment-related. Retrieved data did not allow to distinguish between types of active interventions or perform further analysis. ## Discussion This systematic review and meta-analysis with meta-regression found that individualized exercise interventions versus other active exercise interventions, or passive controls and usual care were associated with reduced self-reported pain intensity and disability at short- and long-term follow-up. Our analysis revealed medium effect sizes for the reduction of pain intensity by individualized exercise with low levels of certainty when compared to active and very low certainty compared to passive treatments at the follow-ups closest to 12 weeks. Disability was reduced with low certainty and small effects size compared to active controls. At long-term follow-up (closest to 12 months) moderate certainty suggests small effect sizes comparing individualized exercise to passive treatments. We could not detect effects on pain intensity at long-term follow-up compared to active controls (low to moderate certainty). Sensitivity analysis (Table 2) revealed on a low level of certainty that the combination of individualized exercise in combination with psychological interventions (e.g., cognitive and/or behavioural therapy) showed moderate effect sizes on pain and disability compared to both active and passive treatments. Effects obtained following individualized exercise were mostly clinically relevant. Sensitivity analysis also showed superiority of motor-controlled individualized interventions (low certainty), and of individualized exercise when compared to real controls (moderate certainty). Meta-regression did not reveal any substantial influencers. These data indicate that general individualized exercise can be recommended in principle to achieve improvements in in pain intensity and disability in low back pain patients From a clinical and therapeutic point of view, we calculated MCIDs implicating individualized exercise to better reduce pain and disability compared to both, active and passive controls. However, MCID mostly failed to be relevant by definition, i.e. below 1.5 points on the VAS for pain and 1.0 point for disability outcomes. Anyhow, we consider (based on the confidence intervals) most effects on pain as probably clinically relevant when individualized exercises are compared to passive measures or other exercises. The clinical relevance may be strengthened due to the following reasons: i) adding a stratification and /or personalisation to the exercise intervention is simple and almost time and cost neutral, ii) at 12 weeks pain intensity was reduced by individualized exercise by 40% and at 26 weeks by 38%, which from a patient’s perspective is of clear benefit, iii) all results are at least consistent in the point that there is a trend (or, even, mostly a significant between-group difference leading to a probable relevant effect) towards individualized treatments that becomes larger when not comparing to active but passive controls, iv) taking into account the strong known placebo effects in low back pain61 emphasizes the small effects retrieved in our study. As all studies were patient-examiner blinded -what hands-on trials cannot be blamed for-this observation seems robust. Compared to other low back pain treatments, the observed effect sizes in our study are superior to, e.g., paracetamol (which has been declared being not effective compared to placebo),53, somewhat larger than therapeutic ultrasound (small to no effects versus placebo),10 non steroidal anti inflammatory drugs (small effects versus placebo),58 spinal manipulative therapy (small effects versus standard care),7 and comparable to acupuncture (low certainty evidence to reduce pain and improve function compared to sham and no treatment).37 Hayden et al. recently assessed the effects of exercise on chronic low back pain and disability to be small compared to no treatment, usual care or placebo comparisons, and other conservative treatments.22 Certainty of evidence is low to moderate, and studies did not meet the threshold for minimal clinically important difference.22 The mean difference between groups as assessed by the meta-analysis on classification-based exercise in low back pain,56 was presented as the difference to all comparators, suggesting small effects. All above mentioned reviews are principally in line with our results, suggesting effects on very low to moderate certainty, which are at first sight not clinically important. The problem of the above made assumptions is that the clinical relevance of the effect cannot just be defined by the MCID.6 Medical assessment should include other factor as well, such as regression, baseline severity, or even expectations. If the MCID is calculated on the basis of a comparison to no treatment controls, it reflects well the clinical state of art.6, 22 In the case of the present systematic review, patients usually received at least advice, and a larger number of no-treatment controlled studies is missing (see Table 1). Calculating the mean differences compared to no treatment controls (n = 4) or usual care and advice only (n = 16; see supplementary data appendix G) resulted in clinically relevant intragroup differences for the individualized exercise group, but not controls, making our findings more likely. Consequently, the MCID is a context-specific value rather than a fixed number,3 and gives insight into relative but also absolute effects. The absolute symptom reduction varied between 40% (pain) and 33% (disability) from baseline, which can indeed be considered clinically relevant from a pain physician’s perspective. Especially with regard to the combined approaches (adding psychological interventions or exercise based on motor control) the reduction of pain intensity (on a low to moderate certainty level) is promising from a clinical point of view. In this context, the impact of the results as shown by Tagliaferri et al. can be regarded clinically relevant.56 Summarising our data, the overall low certainty, RoB, MCID, and SMDs, data support the conclusion that individualized exercise interventions versus other active exercise interventions or usual care or passive controls are associated with clinically relevant reduced self-reported pain intensity and disability. Recent clinical practice guidelines1, 30, 38, 47 are basically in line with our findings. The German national guideline on chronic non-specific low back pain1 strongly recommends the combination of exercise treatments with education, the latter based on behavioural therapy, to treat sub-acute and chronic low back pain, and to promote physical activity. The NICE guidelines38 universally recommend to consider a combined physical and psychological intervention, incorporating a cognitive behavioural approach. Physical programs refers to a group exercise program (biomechanical, aerobic, mind–body or a combination of approaches) for people with specific episodes or flare-up of low back pain with or without sciatica that should take people’s specific needs, preferences and capabilities into account when choosing the type of exercise. The guideline of the North American Spine Association30 recommends cognitive behavioural therapy in combination with physical therapy, as compared with physical therapy alone, to improve pain levels in patients with low back pain over 12 months on level A. Cognitive behavioural therapy in combination with physical therapy is recommended to improve functional outcomes (disability) and return to work in low back pain patients on a level B. We belief that our results strengthen the use of exercise therapies in multimodal settings for low back pain therapies. On the basis of our data, the guideline statements in regard of patients’ needs and differentiation among exercise modalities seem justified. Personalisation is an important option in tailoring exercise to patient’s needs. Different exercise modalities seem to have different impact on pain and disability. Furthermore, the bio-psycho-social dimension of low back pain should also be addressed using adequate psychological interventions. Promising research deficits regarding that should be subject to future research include aspects like digitalisation9 or cost-effectiveness.35. From a therapist’s point of view, different forms of exercise therapy should be compared with each other to determine a potentially superior mode of exercise training for rehabilitation. However, given the current paucity of literature, pairwise meta-analyses may be limited in drawing such conclusions. Network meta-analysis may be more suitable for determining potentially superior modes of exercise training and have recently gained momentum in the field of sports medicine.42 Studies should focus on strong methodological rigor and larger sample sizes to reduce the RoB and increase the certainty in observations. To ensure a low risk of bias, placebo- or sham-controlled trials should be considered.28 Furthermore, the studies should follow current guidelines for intervention description (e.g., the template for intervention description and replication checklist28) to enable transparent evaluation and replication of intervention programs and should report factors potentially influencing the findings (e.g. comorbidities and pain management). Despite of a low adverse effects risk being attributed to exercise therapies,41 the reporting of adverse events in retrieved studies was poor. Our observations mainly rely on one large study,16 including almost 75% (n = 414) of reported adverse events, of which 98 are treatment-related. The strengths of our study include the overall assessment of individualized exercise intervention to give a concise overview of the different modalities how personalisation in exercise therapy might be performed (Supplementary File Appendix C). We also retrieved studies that included patients with sub-chronic low back pain, and sensitivity analysis suggested these patients not to distort our analysis. This group of patients could also benefit from individualized exercise. Statistical sensitivity analyses were finally conducted for all outcomes to further check the robustness and validity of the results. ### Limitations There were no included studies with a low RoB. We also could not assess the effect of individualized exercise on the number of days of absence from work and measures of quality of life, because the included studies did not report these important variables consistently. Consequently, our outcome is restricted to pain or disability only. It should also be noted that the results only apply to land-based interventions. In regard to our certainty assessment downgrading was necessary due to supposed inconsistency. When individual study sample sizes are small, point estimates may vary substantially but, because variation may be explained by chance, *I*2 may be low. Conversely, when study sample size is large, a relatively small difference in point estimates can yield a large *I*2.51 This might also be a reason for the supposed publication bias regarding pain outcomes. In addition, the terms personalized and especially stratified do not exactly mean the same, but address same aspects of medicine. We adhere to the definition, that the term ‘stratification’ more accurately “reflects the realistic effects of medicines at population level, while the term ‘personalized medicine’ reflects the possibly overambitious promise of specifically tailoring a treatment on an individual level.11, 62 In addition, individualisation within our studies covers a broad field of interventions, what should not automatically imply all types of intervention being equally efficient. We are aware that future studies will need to more accurately define exercise in this regard. Finally, although exercise training is considered relatively safe in general,41 adverse events could not be adequately assessed given insufficient reporting. ## Conclusions This systematic review shows on average low-certainty evidence for the effectiveness of individualized exercise on pain and disability in chronic non-specific low back pain. The effects are of clinical importance when assessing individualized exercise by its own. Given the little extra effort to individualise exercise, practitioners should be encouraged to use this approach. Effects are larger when combining exercise and cognitive-behavioural interventions for the treatment of chronic low back pain. With regard to the bio-psycho-social dimension of low back pain, it is important to address psychosocial characteristics, such as inappropriate beliefs about pain, pain catastrophizing, and/or depression, besides bodily functions.50 ## Supporting information Supplementary Files [[supplements/267900_file08.docx]](pending:yes) ## Data Availability All data produced in the present study are available upon reasonable request to the authors ## Footnotes * JF accepts full responsibility for the work and/or the conduct of the study, has access to the data, and controlled the decision to publish. * The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted. * **Conflict of interest** JF received honorary for scientific counselling from the German Medical Acupuncture Association. All other authors declare no conflict of interest. * **Funding** This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. * Updated database search including ther period April 1st 2021 to January 31st 2022. The Resulst Part, Figures and Tables have been revised and updated accordingly. * Received December 16, 2021. * Revision received February 11, 2022. * Accepted February 11, 2022. * © 2022, Posted by Cold Spring Harbor Laboratory The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission. ## REFERENCES 1. 1.Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Nicht-spezifischer Kreuzschmerz. Available at: [http://www.kreuzschmerz.versorgungsleitlinien.de](http://www.kreuzschmerz.versorgungsleitlinien.de). 2. 2.Apeldoorn AT, Ostelo RW, van Helvoirt H, Fritz JM, Knol DL, van Tulder MW, de Vet HC. A randomized controlled trial on the effectiveness of a classification-based system for subacute and chronic low back pain. Spine. 37:1347–1356, 2012 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/BRS.0b013e31824d9f2b&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=22333955&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) 3. 3.Beaton DE, Boers M, Wells GA. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Current opinion in rheumatology. 14:109–114, 2002 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/00002281-200203000-00006&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=11845014&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000174219800006&link_type=ISI) 4. 4.Cherkin DC, Deyo RA, Battié M, Street J, Barlow W. A comparison of physical therapy, chiropractic manipulation, and provision of an educational booklet for the treatment of patients with low back pain. The New England journal of medicine. 339:1021–1029, 1998 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1056/NEJM199810083391502&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=9761803&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000076294800002&link_type=ISI) 5. 5.Chiarotto A, Maxwell LJ, Terwee CB, Wells GA, Tugwell P, Ostelo RW. Roland-Morris Disability Questionnaire and Oswestry Disability Index: Which Has Better Measurement Properties for Measuring Physical Functioning in Nonspecific Low Back Pain? Systematic Review and Meta-Analysis. Physical therapy. 96:1620–1637, 2016 [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToicHRqb3VybmFsIjtzOjU6InJlc2lkIjtzOjEwOiI5Ni8xMC8xNjIwIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjIvMDIvMTEvMjAyMS4xMi4xNi4yMTI2NzkwMC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 6. 6.Cook CE. Clinimetrics Corner: The Minimal Clinically Important Change Score (MCID): A Necessary Pretense. The Journal of manual & manipulative therapy. 16:E82–83, 2008 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1179/jmt.2008.16.4.82E&link_type=DOI) 7. 7.de Zoete A, Rubinstein SM, de Boer MR, Ostelo R, Underwood M, Hayden JA, Buffart LM, van Tulder MW, International IPDSMTg. The effect of spinal manipulative therapy on pain relief and function in patients with chronic low back pain: an individual participant data meta-analysis. Physiotherapy. 112:121–134, 2021 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.physio.2021.03.006&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) 8. 8.Descarreaux M, Normand MC, Laurencelle L, Dugas C. Evaluation of a specific home exercise program for low back pain. Journal of manipulative and physiological therapeutics. 25:497–503, 2002 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1067/mmt.2002.127078&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=12381971&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000178673800002&link_type=ISI) 9. 9.Du S, Hu L, Dong J, Xu G, Chen X, Jin S, Zhang H, Yin H. Self-management program for chronic low back pain: A systematic review and meta-analysis. Patient education and counseling. 100:37–49, 2017 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.pec.2016.07.029&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) 10. 10.Ebadi S, Henschke N, Forogh B, Nakhostin Ansari N, van Tulder MW, Babaei-Ghazani A, Fallah E. Therapeutic ultrasound for chronic low back pain. The Cochrane database of systematic reviews. 7:CD009169, 2020 11. 11.Erikainen S, Chan S. Contested futures: envisioning “Personalized,” “Stratified,” and “Precision” medicine. New Genet Soc. 38:308–330, 2019 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/14636778.2019.1637720&link_type=DOI) 12. 12.Fairbank JC, Couper J, Davies JB, O’Brien JP. The Oswestry low back pain disability questionnaire. Physiotherapy. 66:271–273, 1980 [PubMed](http://medrxiv.org/lookup/external-ref?access_num=6450426&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=6450426&link_type=ISI) 13. 13.Ford JJ, Hahne AJ, Surkitt LD, Chan AY, Richards MC, Slater SL, Hinman RS, Pizzari T, Davidson M, Taylor NF. Individualised physiotherapy as an adjunct to guideline-based advice for low back disorders in primary care: a randomised controlled trial. British journal of sports medicine. 50:237–245, 2016 [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6ODoiYmpzcG9ydHMiO3M6NToicmVzaWQiO3M6ODoiNTAvNC8yMzciO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMi8wMi8xMS8yMDIxLjEyLjE2LjIxMjY3OTAwLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 14. 14.Furlan AD, Malmivaara A, Chou R, Maher CG, Deyo RA, Schoene M, Bronfort G, van Tulder MW, Editorial Board of the Cochrane Back NG. 2015 Updated Method Guideline for Systematic Reviews in the Cochrane Back and Neck Group. Spine. 40:1660–1673, 2015 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/BRS.0000000000001061&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) 15. 15.George SI. What is the effectiveness of a biopsychosocial approach to individual physiotherapy care for chronic low back pain?. Internet Journal of Allied Health Sciences and Practice 6:1–10, 2008 16. 16.Goertz CM, Salsbury SA, Long CR, Vining RD, Andresen AA, Hondras MA, Lyons KJ, Killinger LZ, Wolinsky FD, Wallace RB. Patient-centered professional practice models for managing low back pain in older adults: a pilot randomized controlled trial. BMC Geriatr. 17:235, 2017 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s12877-017-0624-z&link_type=DOI) 17. 17.Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, Jaeschke R, Rind D, Meerpohl J, Dahm P, Schunemann HJ. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of clinical epidemiology. 64:383–394, 2011 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jclinepi.2010.04.026&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=21195583&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) 18. 18.Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, Atkins D, Kunz R, Brozek J, Montori V, Jaeschke R, Rind D, Dahm P, Meerpohl J, Vist G, Berliner E, Norris S, Falck-Ytter Y, Murad MH, Schunemann HJ, Group GW. GRADE guidelines: 9. Rating up the quality of evidence. Journal of clinical epidemiology. 64:1311–1316, 2011 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jclinepi.2011.06.004&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=21802902&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) 19. 19.Hajihasani A, Rouhani M, Salavati M, Hedayati R, Kahlaee AH. The Influence of Cognitive Behavioral Therapy on Pain, Quality of Life, and Depression in Patients Receiving Physical Therapy for Chronic Low Back Pain: A Systematic Review. PM & R: the journal of injury, function, and rehabilitation. 11:167–176, 2019 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.pmrj.2018.09.029&link_type=DOI) 20. 20.Hansen FR, Bendix T, Skov P, Jensen CV, Kristensen JH, Krohn L, Schioeler H. Intensive, dynamic back-muscle exercises, conventional physiotherapy, or placebo-control treatment of low-back pain. A randomized, observer-blind trial. Spine. 18:98–108, 1993 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/00007632-199301000-00015&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=8434332&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1993KL37500015&link_type=ISI) 21. 21.Hartvigsen J, Hancock MJ, Kongsted A, Louw Q, Ferreira ML, Genevay S, Hoy D, Karppinen J, Pransky G, Sieper J, Smeets RJ, Underwood M, Lancet Low Back Pain Series Working G. What low back pain is and why we need to pay attention. Lancet (London, England). 391:2356–2367, 2018 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0140-6736(18)30480-X&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=29573870&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) 22. 22.Hayden JA, Ellis J, Ogilvie R, Malmivaara A, van Tulder MW. Exercise therapy for chronic low back pain. The Cochrane database of systematic reviews. 9:CD009790, 2021 23. 23.Hayden JA, Ellis J, Ogilvie R, Stewart SA, Bagg MK, Stanojevic S, Yamato TP, Saragiotto BT. Some types of exercise are more effective than others in people with chronic low back pain: a network meta-analysis. Journal of physiotherapy. 67:252–262, 2021 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jphys.2021.09.004&link_type=DOI) 24. 24.Heinrich J, Anema JR, de Vroome EM, Blatter BM. Effectiveness of physical training for self-employed persons with musculoskeletal disorders: a randomized controlled trial. BMC public health. 9:200, 2009 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/1471-2458-9-200&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=19549294&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) 25. 25.Henschke N, Ostelo RW, van Tulder MW, Vlaeyen JW, Morley S, Assendelft WJ, Main CJ. Behavioural treatment for chronic low-back pain. The Cochrane database of systematic reviews. 2010:CD002014, 2010 26. 26.Higgins JPT, Savović J, Page MJ, Elbers RG, Sterne JAC: Chapter 8: Assessing risk of bias in a randomized trial. Available at: [https://training.cochrane.org/handbook/current/chapter-08](https://training.cochrane.org/handbook/current/chapter-08) Accessed 11 November, 2021 27. 27.Hill JC, Whitehurst DG, Lewis M, Bryan S, Dunn KM, Foster NE, Konstantinou K, Main CJ, Mason E, Somerville S, Sowden G, Vohora K, Hay EM. Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial. Lancet (London, England). 378:1560–1571, 2011 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0140-6736(11)60937-9&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=21963002&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000296767500021&link_type=ISI) 28. 28.Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, Altman DG, Barbour V, Macdonald H, Johnston M, Lamb SE, Dixon-Woods M, McCulloch P, Wyatt JC, Chan AW, Michie S. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (Clinical research ed.). 348:g1687, 2014 [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYm1qIjtzOjU6InJlc2lkIjtzOjE3OiIzNDgvbWFyMDdfMy9nMTY4NyI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIyLzAyLzExLzIwMjEuMTIuMTYuMjEyNjc5MDAuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 29. 29.Kim SH, Park KN, Kwon OY. Classification-Specific Treatment Improves Pain, Disability, Fear-Avoidance Beliefs, and Erector Spinae Muscle Activity During Walking in Patients With Low Back Pain Exhibiting Lumbar Extension-Rotation Pattern: A Randomized Controlled Trial. Journal of manipulative and physiological therapeutics. 43:123–133, 2020 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jmpt.2019.04.004&link_type=DOI) 30. 30.Kreiner DS, Matz P, Bono CM, Cho CH, Easa JE, Ghiselli G, Ghogawala Z, Reitman CA, Resnick DK, Watters WC, 3rd., Annaswamy TM, Baisden J, Bartynski WS, Bess S, Brewer RP, Cassidy RC, Cheng DS, Christie SD, Chutkan NB, Cohen BA, Dagenais S, Enix DE, Dougherty P, Golish SR, Gulur P, Hwang SW, Kilincer C, King JA, Lipson AC, Lisi AJ, Meagher RJ, O’Toole JE, Park P, Pekmezci M, Perry DR, Prasad R, Provenzano DA, Radcliff KE, Rahmathulla G, Reinsel TE, Rich RL, Jr.., Robbins DS, Rosolowski KA, Sembrano JN, Sharma AK, Stout AA, Taleghani CK, Tauzell RA, Trammell T, Vorobeychik Y, Yahiro AM. Guideline summary review: an evidence-based clinical guideline for the diagnosis and treatment of low back pain. The spine journal: official journal of the North American Spine Society. 20:998–1024, 2020 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.spinee.2020.04.006&link_type=DOI) 31. 31.Lehtola V, Luomajoki H, Leinonen V, Gibbons S, Airaksinen O. Sub-classification based specific movement control exercises are superior to general exercise in sub-acute low back pain when both are combined with manual therapy: A randomized controlled trial. BMC musculoskeletal disorders. 17:135, 2016 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s12891-016-0986-y&link_type=DOI) 32. 32.Lin CW, Haas M, Maher CG, Machado LA, van Tulder MW. Cost-effectiveness of guideline-endorsed treatments for low back pain: a systematic review. European spine journal: official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 20:1024–1038, 2011 33. 33.Macedo LG, Hodges PW, Bostick G, Hancock M, Laberge M, Hanna S, Spadoni G, Gross A, Schneider J. Which Exercise for Low Back Pain? (WELBack) trial predicting response to exercise treatments for patients with low back pain: a validation randomised controlled trial protocol. BMJ open. 11:e042792, 2021 [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoiYm1qb3BlbiI7czo1OiJyZXNpZCI7czoxMjoiMTEvMS9lMDQyNzkyIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjIvMDIvMTEvMjAyMS4xMi4xNi4yMTI2NzkwMC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 34. 34.Maher C, Underwood M, Buchbinder R. Non-specific low back pain. The Lancet. 389:736–747, 2017 35. 35.Miyamoto GC, Lin CC, Cabral CMN, van Dongen JM, van Tulder MW. Cost-effectiveness of exercise therapy in the treatment of non-specific neck pain and low back pain: a systematic review with meta-analysis. British journal of sports medicine. 53:172–181, 2019 [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6ODoiYmpzcG9ydHMiO3M6NToicmVzaWQiO3M6ODoiNTMvMy8xNzIiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMi8wMi8xMS8yMDIxLjEyLjE2LjIxMjY3OTAwLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 36. 36.Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 4:1, 2015 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/2046-4053-4-1&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=25554246&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) 37. 37.Mu J, Furlan AD, Lam WY, Hsu MY, Ning Z, Lao L. Acupuncture for chronic nonspecific low back pain. The Cochrane database of systematic reviews. 12:CD013814, 2020 38. 38.National Guideline C: National Institute for Health and Care Excellence: Clinical Guidelines. In: Low Back Pain and Sciatica in Over 16s: Assessment and Management. National Institute for Health and Care Excellence: Clinical Guidelines, National Institute for Health and Care Excellence (UK) Copyright © NICE, 2016., London, 2016. 39. 39.Nicholas MK, Linton SJ, Watson PJ, Main CJ, Decade of the Flags” Working G. Early identification and management of psychological risk factors (“yellow flags”) in patients with low back pain: a reappraisal. Physical therapy. 91:737–753, 2011 [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToicHRqb3VybmFsIjtzOjU6InJlc2lkIjtzOjg6IjkxLzUvNzM3IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjIvMDIvMTEvMjAyMS4xMi4xNi4yMTI2NzkwMC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 40. 40.Niederer D, Engel T, Vogt L, Arampatzis A, Banzer W, Beck H, Moreno Catala M, Brenner-Fliesser M, Guthoff C, Haag T, Honning A, Pfeifer AC, Platen P, Schiltenwolf M, Schneider C, Trompeter K, Wippert PM, Mayer F. Motor Control Stabilisation Exercise for Patients with Non-Specific Low Back Pain: A Prospective Meta-Analysis with Multilevel Meta-Regressions on Intervention Effects. Journal of clinical medicine. 9, 2020 41. 41.Niemeijer A, Lund H, Stafne SN, Ipsen T, Goldschmidt CL, Jorgensen CT, Juhl CB. Adverse events of exercise therapy in randomised controlled trials: a systematic review and meta-analysis. British journal of sports medicine. 54:1073–1080, 2020 [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6ODoiYmpzcG9ydHMiO3M6NToicmVzaWQiO3M6MTA6IjU0LzE4LzEwNzMiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMi8wMi8xMS8yMDIxLjEyLjE2LjIxMjY3OTAwLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 42. 42.Owen PJ, Miller CT, Mundell NL, Verswijveren S, Tagliaferri SD, Brisby H, Bowe SJ, Belavy DL. Which specific modes of exercise training are most effective for treating low back pain? Network meta-analysis. British journal of sports medicine. 54:1279–1287, 2020 [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6ODoiYmpzcG9ydHMiO3M6NToicmVzaWQiO3M6MTA6IjU0LzIxLzEyNzkiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMi8wMi8xMS8yMDIxLjEyLjE2LjIxMjY3OTAwLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 43. 43.Page MJ, McKenzie JE, Higgins JPT. Tools for assessing risk of reporting biases in studies and syntheses of studies: a systematic review. BMJ open. 8:e019703, 2018 [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoiYm1qb3BlbiI7czo1OiJyZXNpZCI7czoxMToiOC8zL2UwMTk3MDMiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMi8wMi8xMS8yMDIxLjEyLjE2LjIxMjY3OTAwLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 44. 44.Page MJ, McKenzie JE, Kirkham J, Dwan K, Kramer S, Green S, Forbes A. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions. The Cochrane database of systematic reviews. 2014:MR000035, 2014 45. 45.Pergolizzi JV, Jr.., LeQuang JA. Rehabilitation for Low Back Pain: A Narrative Review for Managing Pain and Improving Function in Acute and Chronic Conditions. Pain and therapy. 9:83–96, 2020 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s40122-020-00149-5&link_type=DOI) 46. 46.Petersen T, Larsen K, Nordsteen J, Olsen S, Fournier G, Jacobsen S. The McKenzie method compared with manipulation when used adjunctive to information and advice in low back pain patients presenting with centralization or peripheralization: a randomized controlled trial. Spine. 36:1999–2010, 2011 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/BRS.0b013e318201ee8e&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=21358492&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) 47. 47.Qaseem A, Wilt TJ, McLean RM, Forciea MA, Clinical Guidelines Committee of the American College of P, Denberg TD, Barry MJ, Boyd C, Chow RD, Fitterman N, Harris RP, Humphrey LL, Vijan S. Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Annals of internal medicine. 166:514–530, 2017 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.7326/M16-2367&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=28192789&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) 48. 48.Rasmussen-Barr E, Ang B, Arvidsson I, Nilsson-Wikmar L. Graded exercise for recurrent low-back pain: a randomized, controlled trial with 6-, 12-, and 36-month follow-ups. Spine. 34:221–228, 2009 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/BRS.0b013e318191e7cb&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=19179916&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000263262200002&link_type=ISI) 49. 49.Roland M, Fairbank J. The Roland–Morris Disability Questionnaire and the Oswestry Disability Questionnaire. Spine. 25, 2000 50. 50.Roussel NA, Nijs J, Meeus M, Mylius V, Fayt C, Oostendorp R. Central sensitization and altered central pain processing in chronic low back pain: fact or myth? The Clinical journal of pain. 29:625–638, 2013 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/AJP.0b013e31826f9a71&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=23739534&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000330536500010&link_type=ISI) 51. 51.Rucker G, Schwarzer G, Carpenter JR, Schumacher M. Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol. 8:79, 2008 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/1471-2288-8-79&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=19036172&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) 52. 52.Saner J, Kool J, Sieben JM, Luomajoki H, Bastiaenen CH, de Bie RA. A tailored exercise program versus general exercise for a subgroup of patients with low back pain and movement control impairment: A randomised controlled trial with one-year follow-up. Manual therapy. 20:672–679, 2015 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.math.2015.02.005&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=25770419&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F02%2F11%2F2021.12.16.21267900.atom) 53. 53.Saragiotto BT, Machado GC, Ferreira ML, Pinheiro MB, Abdel Shaheed C, Maher CG. Paracetamol for low back pain. The Cochrane database of systematic reviews.CD012230, 2016 54. 54.Shafshak TS, Elnemr R. The Visual Analogue Scale Versus Numerical Rating Scale in Measuring Pain Severity and Predicting Disability in Low Back Pain. J Clin Rheumatol. 27:282–285, 2021 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/RHU.0000000000001320&link_type=DOI) 55. 55.Tagliaferri SD, Miller CT, Owen PJ, Mitchell UH, Brisby H, Fitzgibbon B, Masse-Alarie H, Van Oosterwijck J, Belavy DL. Domains of Chronic Low Back Pain and Assessing Treatment Effectiveness: A Clinical Perspective. Pain practice: the official journal of World Institute of Pain. 20:211–225, 2020 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/papr.12846&link_type=DOI) 56. 56.Tagliaferri SD, Mitchell UH, Saueressig T, Owen PJ, Miller CT, Belavy DL. Classification Approaches for Treating Low Back Pain Have Small Effects That Are Not Clinically Meaningful: A Systematic Review With Meta-analysis. The Journal of orthopaedic and sports physical therapy.1–49, 2021 57. 57.Ulger O, Demirel A, Oz M, Tamer S. The effect of manual therapy and exercise in patients with chronic low back pain: Double blind randomized controlled trial. Journal of back and musculoskeletal rehabilitation. 30:1303–1309, 2017 58. 58.van der Gaag WH, Roelofs PD, Enthoven WT, van Tulder MW, Koes BW. Non-steroidal anti-inflammatory drugs for acute low back pain. The Cochrane database of systematic reviews. 4:CD013581, 2020 59. 59.van Dieen JH, Reeves NP, Kawchuk G, van Dillen LR, Hodges PW. Analysis of Motor Control in Patients With Low Back Pain: A Key to Personalized Care? The Journal of orthopaedic and sports physical therapy. 49:380–388, 2019 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2519/jospt.2019.7916&link_type=DOI) 60. 60.Van Dillen LR, Norton BJ, Sahrmann SA, Evanoff BA, Harris-Hayes M, Holtzman GW, Earley J, Chou I, Strube MJ. Efficacy of classification-specific treatment and adherence on outcomes in people with chronic low back pain. A one-year follow-up, prospective, randomized, controlled clinical trial. Manual therapy. 24:52–64, 2016 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.math.2016.04.003&link_type=DOI) 61. 61.van Lennep J, Trossel F, Perez R, Otten RHJ, van Middendorp H, Evers AWM, Szadek KM. Placebo effects in low back pain: A systematic review and meta-analysis of the literature. European journal of pain (London, England). 25:1876–1897, 2021 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/ejp.1811&link_type=DOI) 62. 62.WHO: Priority Medicines for Europe and the World 2013 Update p. 180. Available at: [http://www.who.int/medicines/areas/priority\_medicines/MasterDocJune28\_FINAL\_Web.pdf](http://www.who.int/medicines/areas/priority_medicines/MasterDocJune28_FINAL_Web.pdf) Accessed Jan 31st, 2021 63. 63.Wong CK, Mak RY, Kwok TS, Tsang JS, Leung MY, Funabashi M, Macedo LG, Dennett L, Wong AY. Prevalence, Incidence, and Factors Associated With Non-Specific Chronic Low Back Pain in Community-Dwelling Older Adults Aged 60 Years and Older: A Systematic Review and Meta-Analysis. The journal of pain. 2021 64. 64.Zemedikun DT, Kigozi J, Wynne-Jones G, Guariglia A, Roberts T. Methodological considerations in the assessment of direct and indirect costs of back pain: A systematic scoping review. PloS one. 16:e0251406, 2021 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1371/journal.pone.0251406&link_type=DOI)